Skip to search formSkip to main contentSkip to account menu

fendosal

Known as: 5-(4,5-dihydro-2-phenyl-3H-benz(e)indol-3-yl)salicylic acid, Benzoic acid, 5-(4,5-dihydro-2-phenyl-3H-benz(e)indol-3-yl)-2-hydroxy- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
Summary Plasminogen activator inhibitor-1 (PAI-1), the primary physiological inhibitor of both tissue-type plasminogen activator… 
1985
1985
Fendosal (200 mg) was given orally to each of two separate groups of twelve healthy male volunteers on separate occasions to… 
1983
1983
The purpose of this study was to characterize the analgesic dose‐effect curve of orally administered fendosal, relative to… 
1980
1980
A simple, rapid, and sensitive procedure is described for the determination of Fendosal in plasma. After extraction of Fendosal… 
1978
1978
The analgesic efficacy of fendosal, a new nonsteroidal anti‐inflammatory agent structurally related to salicylic acid, was… 
1978
1978
Fendosal (HP 129) is one of a series of potent non-steroidal anti-inflammatory agents. Fendosal was compared with aspirin in… 
1977
1977
2-Carboxyaryl-substituted dihydrobenz[e]indoles, tetrahydroindoles, and tetrahydrobenzofurans have been synthesized as structural…